Background: We aimed to find the relationship between the clinical characteristics and mucus plug formation and developed models to predict mucus plug formation in refractory Mycoplasma pneumoniae pneumonia (RMPP) infection. Methods: RMPP patients treated with bronchoscopy were retrospectively enrolled in the study between November 2011 and November 2015. Multivariate logistic regression was performed to identify independent predictors of mucus plug formation. Results: Of the 173 RMPP patients enrolled, the mucus plug group accounted for 82 (47.4%) cases. Multivariate logistic regression analysis identified age, fever duration, C-reactive protein (CRP) and lactic dehydrogenase (LDH) as independent risk factors for mucus plug. We assigned one point for age, length of fever and CRP and two points for LDH. Using this predicted score, we identified patients with mucus plug with 71.8% sensitivity and 78.9% specificity. Conclusions: Our predictive models based on demographic and laboratory variables accurately predicted mucus plug formation in initial treatment of patients with RMPP.
I N T R O D U C T I O N
Mycoplasma pneumoniae (MP) is now recognized as one of the main pathogens causing communityacquired pneumonia (CAP) in young adults and children [1] . MP pneumonia (MPP) accounts for as many as 40% of the CAP cases in children [2] , increasing the rate of morbidity, mortality, as well as the cost of health care in our society. Macrolides are now the best antibiotics of choice for pediatric patients with respect to effectiveness and side effects. Although MPP is usually a benign, self-limited disease, some cases are reported to develop into refractory MPP (RMPP) despite the administration of appropriate antibiotics [3] . In recent years, an increasing number of RMPP patients are being reported, which is because of excessive immunological inflammation and macrolide-resistant MP infection [4] . Corticosteroid treatment has been reported to be efficacious and well tolerated by downregulating the cell-mediated immune response and therefore reducing the immune-mediated pulmonary injury, improving the prognosis of RMPP [3, [5] [6] [7] .
V C The Author [2016] . Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com However, some patients with RMPP do not respond to the treatment of macrolide together with corticosteroids because of the formation of bronchial mucus [8, 9] .
Mucus plug was commonly seen in RMPP patients with lobar/segmental consolidation or atelectasis under bronchoscopy [8] . RMPP patients with mucus plug formation may have delayed radiographic resolution. Some even lead to long-standing pulmonary sequelae such as bronchiectasis [8] . Early identification of likely mucus plug formation that will require bronchoscopy therapy might reduce risk of delayed radiographic resolution and even long-standing pulmonary sequelae. However, a method for predicting mucus plug formation in RMPP patients has not been established.
In the present study, we identified the risk factors associated with bronchial mucus plugs formation, and furthermore, we generated a predicted score using the clinical records of RMPP patients in the city of Suzhou, China.
M A T E R I A L S A N D M E T H O D S

Patients and definitions
We retrospectively reviewed the clinical records of 173 RMPP patients treated with fiber optic bronchoscopy in Children's Hospital of Soochow University between November 2011 and November 2015. The included patients were all aged between 1 month and 14 years, with complete medical data. MPP was confirmed when (i) a pulmonary infiltrate was present on a chest radiograph in combination with fever, cough or auscultatory findings, which was consistent with pneumonia; and (ii) MP DNA was detected in bronchoalveolar lavage fluid (BALF) by real-time polymerase chain reaction (PCR), and specific IgM and IgG antibodies against MP in paired sera were detected by enzyme-linked immunosorbent assays (ELISA). RMPP was diagnosed in the presence of a prolonged high fever (>38.5 C) and radiological deterioration after therapy with a macrolide combined with oral prednisolone (azithromycin 10 mg/day and prednisolone 1-2 mg/day) for !7 days [10] . Fiber optic bronchoscopy was performed when RMPP was confirmed, and BALF cytomorphology was also performed. Exclusion criteria for our study included patients with congenital heart diseases, heredity metabolic diseases, neurological disorders, bronchopulmonary dysplasia, immunodeficiency and coinfected with other pathogens. These RMPP patients treated with fiber optic bronchoscopy were classified into mucus plug group and nonmucus plug group. The mucus plug group consisted of patients showing mucus plug formation under bronchoscopy. Non-mucus plug group consisted of patients not showing mucus plug under bronchoscopy. The study was approved by the Ethics Committee of Children's Hospital of Soochow University.
Data collection
Data regarding demographic, clinical and laboratory characteristics were documented. Demographic and clinical characteristics included age, gender, length of hospital stay, peak body temperature and fever duration. Laboratory specimens were obtained including blood, nasopharyngeal aspirates (NPAs) and BALF. Laboratory data like white blood cell count, % neutrophils, platelet (PLT) count, C-reactive protein (CRP), lactic dehydrogenase (LDH), fibrinogen, humoral immunity, cell-mediated immunity and NPAs were obtained during the first 24 h of hospitalization.
BALF collection and BALF collection and real-time PCR for MP detection The procedure of BALF collection using fiber optic bronchoscopy has been described previously [11] . First, BALF samples were used for MP DNA detection and other BALF samples were used for cell count after centrifugation at 200Â g for 10 min at 4 C. MP DNA was detected using a real-time PCR commercial kit (Daan Gene Co. Ltd, Guangzhou, China). In short, one sample of BALF was shaken for 30 s and centrifuged at 15 000 Â g for 5 min, and the sediment was collected for DNA extraction from a 400 ll sample in accordance with the manufacturer's instructions. PCR amplification was conducted using commercial primers and probes. Quantification curves were plotted using several concentrations of standard control samples.
Serology of MP
Specific IgM and IgG antibodies against MP were detected in serum samples of patients in the acute phase of MPP (on admission) and convalescent phase (on discharge), respectively, using a commercial ELISA kit (Serion ELISA classic MP IgG/IgM, Institute Virion/Serion, Würzburg, Germany) according to the manufacturer's instructions.
Statistical analyses
Statistical analyses were conducted using SPSS 22.0. Data are expressed as mean 6 SD, median with quartiles or number with percentage as appropriate. Parametric and nonparametric comparative tests for continuous data and v 2 test for categorical data were used to compare variables between groups. p < 0.05 was considered statistically significant. A univariate analysis for 25 influence factors was performed. The variables identified by univariate analysis (p < 0.05) were put into the multivariate regression model to analyze independent risk factors for formation of mucus plug. Continuous variables were converted to dichotomous variables according to the upper or lower quartile for each independent predictor identified by the multivariate logistic regression. According to the results of multivariate logistic regression, we construct a predicted model of mucus plug formation. The score point of each risk factor was determined by the value of odds ratio (OR). Based on the OR value of significant risk factors, we assigned one point for age, length of fever and CRP and two points for LDH. Area under the receiver operating characteristics (ROC) curve was to evaluate capacity of the model.
R E S U L T S
Patients diagnosis and characteristics A total of 173 RMPP patients diagnosed and treated with fiber optic bronchoscopy in Children's Hospital of Soochow University between November 2011 and November 2015 were enrolled in the study. The mucus plug group (Fig. 1) accounted for 82 (47.4%) cases and non-mucus plug group for 91 (52.6%) cases. The mean age of mucus plug and non-mucus plug patients was 6.7 6 2.5 years and 5.4 6 3.0 years, respectively, with a significant difference (p < 0.05). Male percentage was 54.9% (45 of 82) in the mucus plug patients and 52.7% (42 of 91) in the non-mucus plug patients, with no statistical difference. The mucus plug patients had a longer fever duration, a higher peak body temperature and a higher rate of pleural effusion. Besides these parameters, other laboratory parameters were also compared. Significant differences (p<0.05) were demonstrated in N%, PLT, CRP, LDH, CD3-CD 19þ, CD3þ, CD3 þ CD4þ and CD3-CD(16 þ 56)þ between the two groups ( Table 1) .
Predictive risk factors for mucus plug formation Univariate analysis identified 12 variables (age, fever duration, peak body temperature, presence of pleural effusion, N%, PLT, CRP, LDH, CD3þ, CD3 þ CD4þ, CD3-CD(16 þ 56)þ, CD3-CD19þ) as significant risk factors (p < 0.05, Table 1 ). The 12 variables were put into the multivariate regression model. Multivariate logistic regression identified age, fever duration, CRP and LDH as independent risk factors for formation of mucus plug (p < 0.05, Table  2 ). The area under the ROC curve of this regression Based on the OR value of significant risk factors, we assigned one point for age, length of fever and CRP and two points for LDH (Table 3) . Using this predicted model, we identified the patients with mucus plug with 71.8% sensitivity and 78.9% specificity. The area under the ROC curve of this predicted model was 0.78 (95% CI 0.71-0.85; Fig. 2 ). On the basis of the predicted score, two risk strata were identified: low risk, with scores of 0-3, encompassing 126 children with an incidence rate of mucus plug formation of 34.1%; and high risk, with scores of 4-5, encompassing 47 children with an incidence rate of mucus plug formation of 80.9% (Fig. 3) .
D I S C U S S I O N
To date, this is the first study that analyzed risk factors associated with the formation of bronchial mucus plug in patients with RMPP. We found that CRP, LDH, age and fever duration were associated with the formation of bronchial mucus plug. In essence, these findings suggest that RMPP patients who are older, have higher CRP and LDH and longer fever duration are at higher risk of developing bronchial mucus plug. Thus, the formation of bronchial mucus plug in RMPP is not a random phenomenon, but is another manifestation of cellular immunological responses. The immune system in older children was relatively more mature than that in younger children, and inappropriate immune response to MP was easy to produce excessive inflammatory reaction, which might contribute to the development of RMPP and the formation of mucus plug. Previous studies have reported that the median age of the RMPP patients was much more that of the MPP patients [12, 13] . Our study also showed that older patients are at higher risk of more severe MP infection and developing bronchial mucus plug. CRP is a gross biochemical index of inflammation and is used commonly in the clinical setting. CRP reflected the acute severe systemic inflammatory reactions to MP infection, and was suggestive of a well-developed immune system. Zhang et al. [13] found that CRP ! 16.5 mg/l was a significant predictor of RMPP. LDH was considered as an indicator of lung damage or inflammation [14] . Several studies also found that serum LDH was elevated in RMPP [13, 15] . In our study, we also found that RMPP patients with mucus plug had higher CRP and LDH than those without mucus plug formation (p < 0.001), which highlighted the use of CRP and LDH in RMPP. Mucus plug has been extensively studied in asthma. Abnormalities in cilia and transport of airway secretions play an important role in the formation of mucus plug in asthma [16] [17] [18] . Occasionally, segmental or subsegmental atelectasis develops, but in most series, radiographically visible atelectasis is uncommon [16] . However, in RMPP, radiographically visible atelectasis is common. It is the manifestation of a large mucous plug in a major bronchus. Our previous studies revealed that strong cellular immunological responses cause severe cilia abnormalities in MPP [11, 19] . Severe cilia abnormalities reduce the immune function of the airways and disrupt the mucociliary clearance, causing a mucous plug that is responsible for the development of atelectasis. Thus, cilia abnormalities play a central role in the formation of mucus plug in MPP. The usefulness of a risk score for identification of mucus plug in RMPP patients from baseline clinical and laboratory variables could identify patients who might benefit from adjunctive anti-inflammatory and bronchoalveolar lavage (BAL) therapies. The most extensively studied adjunctive therapy is corticosteroids [3, 20, 21] . Because RMPP patients with high scores are at high risk for mucus plug formation, early use of adjunctive corticosteroids and BAL therapies should be considered in such patients to reduce the occurrence of radiographically visible atelectasis. Recent reports suggest that BAL appeared to be efficacious for RMPP with radiologically proven large pulmonary lesions, and early application of BAL may be more beneficial [8] . No firm conclusions can be reached at this time about the usefulness of each treatment in RMPP; therefore, prospective clinical trials are warranted to determine the role of these therapies in patients at high risk for mucus plug.
The study should be considered in light of certain limitations. First, selection bias may have occurred because our study was retrospective, and additional prospective studies are needed. Second, the collection of the laboratory samples did not occur on the same day after the disease onset, which has produced bias. Furthermore, our study was based on a single center for data, which might have potential biases.
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